Patients with EO-rheumatoid arthritis (EO-RA) have higher serum interleukin-6 levels and lower serum TNFα levels than patients with NEO-RA, and high levels of TNFα are associated with higher risk of hospitalization and death26–28. The gene discussed is IL6; the disease is rheumatoid arthritis.